Oxinas Partners Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,365
Closed -$213K 120
2023
Q3
$213K Sell
1,365
-261
-16% -$43.1K 0.16% 104
2023
Q2
$269K Sell
1,626
-144
-8% -$23.2K 0.18% 92
2023
Q1
$274K Sell
1,770
-110
-6% -$17.8K 0.2% 83
2022
Q4
$332K Buy
1,880
+26
+1% +$4.49K 0.28% 64
2022
Q3
$303K Sell
1,854
-93
-5% -$15.7K 0.25% 69
2022
Q2
$346K Buy
1,947
+141
+8% +$25.1K 0.26% 71
2022
Q1
$320K Sell
1,806
-26
-1% -$4.42K 0.2% 82
2021
Q4
$313K Sell
1,832
-32
-2% -$5.24K 0.18% 108
2021
Q3
$301K Sell
1,864
-158
-8% -$27K 0.18% 116
2021
Q2
$333K Sell
2,022
-1,115
-36% -$185K 0.19% 113
2021
Q1
$516K Buy
3,137
+1,681
+115% +$272K 0.33% 80
2020
Q4
$229K Buy
+1,456
New +$215K 0.17% 104

Other funds holding JNJ

Oxinas Partners Wealth Management's JNJ Position: Q4 2023 in Review

Oxinas Partners Wealth Management sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 1,365 shares — an estimated $213K sold.

Oxinas Partners Wealth Management first reported a position in JNJ in Q4 2020 and held it in 12 quarters. The position peaked at $516K in Q1 2021. 3,869 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Oxinas Partners Wealth Management reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
  • Oxinas Partners Wealth Management sold 1,365 Johnson & Johnson shares in Q4 2023, an estimated $213K.
  • Oxinas Partners Wealth Management first reported a position in Johnson & Johnson in Q4 2020 and held it in 12 quarters.
  • Oxinas Partners Wealth Management's Johnson & Johnson position peaked at $516K in Q1 2021.
  • 3,869 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Oxinas Partners Wealth Management's 13F filing for Q4 2023, filed 22 Jan 2024.